What is CEIV Pharma?
The pharmaceutical industry has relied heavily on the airline industry for its speed and efficiency in transporting highvalue, time- and temperature-sensitive cargo.
April 1, 2015
The pharmaceutical industry has relied heavily on the airline industry for its speed and efficiency in transporting highvalue, time- and temperature-sensitive cargo. However, until last year, there were no global certification standards that could be internationally recognised and implemented.
“IATA has been working very hard with our stakeholders to ensure product integrity for these types of shipments,” said Tony Tyler, IATA director general and CEO. “The Center of Excellence for Independent Validators (CEIV Pharma) certification programme provides participants in the air cargo value chain with the tools to ensure that they are operating to the highest standards for the transport of what in many cases are life-saving drugs and medicines. And it will give pharmaceutical companies confidence and assurance that their coldchain logistics requirements are being met through an independent certification process.”
And gaining that confidence is critical considering the global pharmaceutical industry spent close to US$8.36 billion on cold chain logistics in 2014 and is expected to expand to more than $10 billion by 2018.
The CEIV pharma certification programme aims at improving the handling of pharmaceutical cargo by upgrading, aligning and standardising the pharma handling processes at every location in the supply chain.
It takes the binding requirements of the national and international Good Distribution Practices (GDP) regulations that are already in place and harmonises these into a globally valid programme using airfreight-focused, on-site training and an integrated, independent audit capability. The programme focuses on equipment requirements, adequate storage facilities, efficient and effective pharmaceutical handling procedures and raising internal pharmaceutical handling know-how.